CLINICAL_TRIALS
trial_result
· 2024-12-09
Clinical Trial Update: Phase 1 Study of 68Ga-R8760 [Phase 1]
Summary
The Phase 1 trial of the radiopharmaceutical 68Ga-R8760 for adrenocortical carcinoma has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Radionetics Oncology | Conditions: Adrenocortical Carcinoma | Phase 1 | Status: TERMINATED